本页面由Tiger Trade Technology Pte. Ltd.提供服务

Quoin Pharmaceuticals

6.58
+0.09001.39%
盘后6.580.00000.00%18:48 EDT
成交量:1.53万
成交额:9.92万
市值:1,186.79万
市盈率:-0.44
高:6.71
开:6.71
低:6.35
收:6.49
52周最高:41.80
52周最低:5.27
股本:180.36万
流通股本:144.14万
量比:0.50
换手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-14.7963
每股收益(LYR):-66.9021
净资产收益率:-141.59%
总资产收益率:-56.41%
市净率:0.90
市盈率(LYR):-0.10

数据加载中...

2023/03/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/28

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/02/08

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/03

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/08/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/04

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/08/03

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/04/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/15

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/04/14

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/05

SEC问询函

CORRESP [Cover] - Correspondence